Chandauli Hospital Introduces Free Single-Dose FCM Treatment for Anaemia
By 1 May 2026, the Government Women’s Hospital in Mughalsarai, Chandauli, had introduced free intravenous ferric carboxymaltose (FCM) for pregnant and breastfeeding women with anaemia. It was the first introduction of the treatment in the district.
FCM Treatment and Administration
FCM is a single-dose treatment for iron-deficiency anaemia in pregnant and lactating women. It can deliver up to 1,000 mg of iron in one sitting over 15–30 minutes. This offers an alternative to iron sucrose, which requires repeated injections and hospital visits. Studies indicate FCM is safe and effective from the second trimester onwards, with fewer adverse effects than iron sucrose.
Uttar Pradesh Rollout
Uttar Pradesh rolled out intravenous FCM therapy in April 2026 under the Anemia Mukt Bharat initiative. The treatment is intended to be available free of charge to beneficiaries through public health systems.
Important Facts for Exams
- When IV iron is used: Intravenous iron may be used when oral treatment is not tolerated, absorption is seriously compromised, or a rapid improvement is required.
- Formulation approach: Parenteral iron formulations use compounds including carboxymaltose to limit the adverse effects and toxicity associated with soluble iron salts.